Comparison of Chronologic Change in the Size and Contrast-Enhancement of Ablation Zones on CT Images after Irreversible Electroporation and Radiofrequency Ablation |
Scheck, Jonas
(Department of Diagnostic and Interventional Radiology, Aachen University Hospital, RWTH Aachen University)
Bruners, Philipp (Department of Diagnostic and Interventional Radiology, Aachen University Hospital, RWTH Aachen University) Schindler, David (Institute of Medical Statistics, Aachen University Hospital, RWTH Aachen University) Kuhl, Christiane (Department of Diagnostic and Interventional Radiology, Aachen University Hospital, RWTH Aachen University) Isfort, Peter (Department of Diagnostic and Interventional Radiology, Aachen University Hospital, RWTH Aachen University) |
1 | Park MH, Rhim H, Kim YS, Choi D, Lim HK, Lee WJ. Spectrum of CT findings after radiofrequency ablation of hepatic tumors. Radiographics 2008;28:379-390; discussion 390-392 DOI |
2 | Kim SD, Yoon SG, Sung GT. Radiofrequency ablation of renal tumors: four-year follow-up results in 47 patients. Korean J Radiol 2012;13:625-633 DOI |
3 | Kim HB, Sung CK, Baik KY, Moon KW, Kim HS, Yi JH, et al. Changes of apoptosis in tumor tissues with time after irreversible electroporation. Biochem Biophys Res Commun 2013;435:651-656 DOI |
4 | Golberg A, Bruinsma BG, Jaramillo M, Yarmush ML, Uygun BE. Rat liver regeneration following ablation with irreversible electroporation. PeerJ 2016;4:e1571 DOI |
5 | Martins NM, Santos NA, Curti C, Bianchi ML, Santos AC. Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. J Appl Toxicol 2008;28:337-344 DOI |
6 | Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008;9:231-241 DOI |
7 | Kim YS, Rhim H, Lim HK, Choi D, Lee MW, Park MJ. Coagulation necrosis induced by radiofrequency ablation in the liver: histopathologic and radiologic review of usual to extremely rare changes. Radiographics 2011;31:377-390 DOI |
8 | Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 2012;30:1323-1341 DOI |
9 | Dollinger M, Jung EM, Beyer L, Niessen C, Scheer F, Muller-Wille R, et al. Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones. J Vasc Interv Radiol 2014;25:1589-1594 DOI |
10 | Li S, Zeng Q, Zhong R, Mao S, Shen L, Wu P. [Liver regeneration after radiofrequency ablation versus irreversible electroporation]. Zhonghua Yi Xue Za Zhi 2015;95:66-68 |
11 | Cheng RG, Bhattacharya R, Yeh MM, Padia SA. Irreversible electroporation can effectively ablate hepatocellular carcinoma to complete pathologic necrosis. J Vasc Interv Radiol 2015;26:1184-1188 DOI |
12 | Cheung W, Kavnoudias H, Roberts S, Szkandera B, Kemp W, Thomson KR. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes. Technol Cancer Res Treat 2013;12:233-241 DOI |
13 | Scheffer HJ, Nielsen K, de Jong MC, van Tilborg AA, Vieveen JM, Bouwman AR, et al. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. J Vasc Interv Radiol 2014;25:997-1011; quiz 1011 DOI |
14 | Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality--clinical implications. Technol Cancer Res Treat 2007;6:37-48 DOI |
15 | Thomson KR, Cheung W, Ellis SJ, Federman D, Kavnoudias H, Loader-Oliver D, et al. Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 2011;22:611-621 DOI |
16 | Niessen C, Jung EM, Wohlgemuth WA, Trabold B, Haimerl M, Schreyer A, et al. Irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft. Korean J Radiol 2013;14:797-800 DOI |
17 | Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005;33:223-231 DOI |
18 | Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 2010;255:426-433 DOI |
19 | Maor E, Ivorra A, Leor J, Rubinsky B. The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 2007;6:307-312 DOI |
20 | Chung DJ, Sung K, Osuagwu FC, Wu HH, Lassman C, Lu DS. Contrast enhancement patterns after irreversible electroporation: experimental study of CT perfusion correlated to histopathology in normal porcine liver. J Vasc Interv Radiol 2016;27:104-111 DOI |
21 | Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 2000;88:2452-2463 DOI |
22 | Lee YJ, Lu DS, Osuagwu F, Lassman C. Irreversible electroporation in porcine liver: acute computed tomography appearance of ablation zone with histopathologic correlation. J Comput Assist Tomogr 2013;37:154-158 DOI |
23 | Goldberg SN, Kamel IR, Kruskal JB, Reynolds K, Monsky WL, Stuart KE, et al. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy. AJR Am J Roentgenol 2002;179:93-101 DOI |
24 | Keil S, Bruners P, Schiffl K, Sedlmair M, Muhlenbruch G, Gunther RW, et al. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease. Cardiovasc Intervent Radiol 2010;33:297-306 DOI |
25 | Lim HK, Choi D, Lee WJ, Kim SH, Lee SJ, Jang HJ, et al. Hepatocellular carcinoma treated with percutaneous radiofrequency ablation: evaluation with follow-up multiphase helical CT. Radiology 2001;221:447-454 DOI |
26 | Siperstein A, Garland A, Engle K, Rogers S, Berber E, Foroutani A, et al. Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors. Ann Surg Oncol 2000;7:106-113 DOI |
27 | Morimoto M, Sugimori K, Shirato K, Kokawa A, Tomita N, Saito T, et al. Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods. Hepatology 2002;35:1467-1475 DOI |
28 | Bertrand J, Caillol F, Borentain P, Raoul JL, Heyries L, Bories E, et al. Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients. Hepat Med 2015;7:21-27 |